 Randi Johnson
Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans | 14 | 2026 | 842 | 2.750 |
Why?
| | Autoimmunity | 18 | 2026 | 930 | 2.550 |
Why?
| | Diabetes Mellitus, Type 1 | 24 | 2026 | 3910 | 2.250 |
Why?
| | DNA Methylation | 10 | 2026 | 664 | 2.120 |
Why?
| | Seroconversion | 3 | 2026 | 48 | 1.260 |
Why?
| | Nasal Mucosa | 3 | 2025 | 112 | 1.220 |
Why?
| | Asthma | 5 | 2025 | 1774 | 1.210 |
Why?
| | Diet | 6 | 2021 | 1270 | 1.010 |
Why?
| | Genetic Predisposition to Disease | 8 | 2025 | 2350 | 0.930 |
Why?
| | Autoantibodies | 8 | 2026 | 1505 | 0.870 |
Why?
| | Metabolomics | 4 | 2024 | 724 | 0.700 |
Why?
| | Dinoprostone | 1 | 2022 | 180 | 0.680 |
Why?
| | B-Lymphocytes | 1 | 2026 | 875 | 0.640 |
Why?
| | Neutrophils | 1 | 2026 | 1118 | 0.630 |
Why?
| | Lipid Metabolism | 2 | 2024 | 524 | 0.630 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 374 | 0.630 |
Why?
| | Gene Expression Regulation | 3 | 2025 | 2591 | 0.620 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2021 | 178 | 0.580 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 106 | 0.580 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2025 | 1129 | 0.570 |
Why?
| | Adolescent Health | 1 | 2019 | 37 | 0.570 |
Why?
| | Case-Control Studies | 9 | 2026 | 3603 | 0.570 |
Why?
| | Glutens | 4 | 2021 | 60 | 0.490 |
Why?
| | Child, Preschool | 17 | 2026 | 11790 | 0.460 |
Why?
| | Schools | 1 | 2019 | 450 | 0.460 |
Why?
| | Child | 22 | 2026 | 22600 | 0.440 |
Why?
| | Risk Factors | 12 | 2025 | 10796 | 0.430 |
Why?
| | Sexual Behavior | 1 | 2019 | 493 | 0.430 |
Why?
| | Precision Medicine | 3 | 2023 | 454 | 0.420 |
Why?
| | Rural Population | 1 | 2019 | 657 | 0.400 |
Why?
| | Adolescent Behavior | 1 | 2019 | 497 | 0.400 |
Why?
| | Female | 31 | 2026 | 78304 | 0.390 |
Why?
| | Health Behavior | 1 | 2019 | 786 | 0.380 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 2573 | 0.370 |
Why?
| | Male | 26 | 2026 | 72431 | 0.360 |
Why?
| | Biological Specimen Banks | 2 | 2023 | 105 | 0.350 |
Why?
| | Epigenesis, Genetic | 4 | 2026 | 669 | 0.340 |
Why?
| | Humans | 39 | 2026 | 144667 | 0.340 |
Why?
| | Vitamin D | 2 | 2026 | 400 | 0.300 |
Why?
| | Disease Progression | 5 | 2026 | 2847 | 0.290 |
Why?
| | Eating | 3 | 2021 | 388 | 0.290 |
Why?
| | CpG Islands | 3 | 2023 | 161 | 0.280 |
Why?
| | Follow-Up Studies | 5 | 2026 | 5414 | 0.270 |
Why?
| | Adolescent | 12 | 2026 | 22409 | 0.250 |
Why?
| | Genome-Wide Association Study | 3 | 2024 | 1374 | 0.250 |
Why?
| | Celiac Disease | 2 | 2020 | 309 | 0.240 |
Why?
| | Biomarkers | 4 | 2026 | 4261 | 0.230 |
Why?
| | Colorado | 4 | 2026 | 4558 | 0.220 |
Why?
| | HLA Antigens | 1 | 2026 | 235 | 0.220 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2024 | 25 | 0.210 |
Why?
| | Multifactorial Inheritance | 1 | 2025 | 190 | 0.210 |
Why?
| | Pedigree | 1 | 2025 | 515 | 0.210 |
Why?
| | Genetics, Population | 1 | 2025 | 215 | 0.210 |
Why?
| | Diet Surveys | 2 | 2021 | 90 | 0.200 |
Why?
| | Oxylipins | 2 | 2023 | 47 | 0.200 |
Why?
| | Pregnancy | 6 | 2025 | 7122 | 0.200 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.190 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1322 | 0.190 |
Why?
| | Prognosis | 3 | 2026 | 4312 | 0.180 |
Why?
| | Transcriptome | 2 | 2025 | 1036 | 0.180 |
Why?
| | Infant | 9 | 2026 | 10023 | 0.180 |
Why?
| | Eicosanoids | 1 | 2022 | 58 | 0.180 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 49 | 0.170 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2025 | 641 | 0.170 |
Why?
| | Gene Expression | 1 | 2025 | 1476 | 0.160 |
Why?
| | Pregnancy Trimester, Third | 1 | 2021 | 114 | 0.160 |
Why?
| | Breast Feeding | 2 | 2021 | 444 | 0.160 |
Why?
| | Dietary Sucrose | 1 | 2020 | 50 | 0.160 |
Why?
| | Sugars | 1 | 2020 | 40 | 0.150 |
Why?
| | Smoking | 2 | 2025 | 1467 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 154 | 0.150 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 590 | 0.150 |
Why?
| | Phospholipids | 1 | 2021 | 214 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2137 | 0.150 |
Why?
| | Thinness | 1 | 2019 | 98 | 0.140 |
Why?
| | Early Diagnosis | 1 | 2019 | 249 | 0.140 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1766 | 0.140 |
Why?
| | Dietary Proteins | 1 | 2019 | 135 | 0.140 |
Why?
| | Pregnancy in Adolescence | 1 | 2019 | 82 | 0.140 |
Why?
| | Prospective Studies | 5 | 2023 | 7994 | 0.140 |
Why?
| | Postpartum Period | 1 | 2021 | 368 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 444 | 0.130 |
Why?
| | Vulnerable Populations | 1 | 2019 | 175 | 0.130 |
Why?
| | Guatemala | 1 | 2019 | 344 | 0.130 |
Why?
| | Child Health | 1 | 2019 | 153 | 0.130 |
Why?
| | Health Surveys | 1 | 2019 | 517 | 0.120 |
Why?
| | Child Behavior | 1 | 2019 | 236 | 0.120 |
Why?
| | Longitudinal Studies | 4 | 2026 | 2942 | 0.120 |
Why?
| | Risk-Taking | 1 | 2019 | 324 | 0.120 |
Why?
| | Pilot Projects | 1 | 2022 | 1886 | 0.120 |
Why?
| | Environmental Exposure | 1 | 2020 | 574 | 0.110 |
Why?
| | Pregnancy, Unplanned | 1 | 2015 | 48 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1076 | 0.110 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 154 | 0.110 |
Why?
| | Contraceptive Agents, Female | 1 | 2015 | 80 | 0.100 |
Why?
| | Safety-net Providers | 1 | 2015 | 128 | 0.100 |
Why?
| | Overweight | 1 | 2019 | 606 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1700 | 0.100 |
Why?
| | Students | 1 | 2019 | 657 | 0.100 |
Why?
| | Young Adult | 4 | 2026 | 14122 | 0.090 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5870 | 0.090 |
Why?
| | Health Promotion | 1 | 2019 | 771 | 0.090 |
Why?
| | Aged | 2 | 2023 | 25955 | 0.090 |
Why?
| | Infant, Newborn | 2 | 2021 | 6399 | 0.090 |
Why?
| | Adult | 7 | 2026 | 40489 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1121 | 0.090 |
Why?
| | Premature Birth | 1 | 2015 | 376 | 0.080 |
Why?
| | Insulin | 1 | 2020 | 2502 | 0.070 |
Why?
| | Genotype | 2 | 2026 | 1847 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6041 | 0.060 |
Why?
| | Incidence | 2 | 2026 | 2892 | 0.060 |
Why?
| | Age of Onset | 1 | 2026 | 551 | 0.050 |
Why?
| | Fibronectins | 1 | 2024 | 132 | 0.050 |
Why?
| | Haplotypes | 1 | 2025 | 495 | 0.050 |
Why?
| | Cohort Studies | 2 | 2026 | 5957 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2023 | 171 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 319 | 0.040 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 68 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 385 | 0.040 |
Why?
| | Origin of Life | 1 | 2020 | 10 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2020 | 35 | 0.040 |
Why?
| | Isotopes | 1 | 2020 | 34 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | HLA-DR4 Antigen | 1 | 2020 | 74 | 0.040 |
Why?
| | HLA-DR3 Antigen | 1 | 2020 | 76 | 0.040 |
Why?
| | Peroxidase | 1 | 2020 | 167 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 732 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 325 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 751 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 587 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 141 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2019 | 153 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 481 | 0.040 |
Why?
| | Transglutaminases | 1 | 2019 | 159 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2020 | 369 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 450 | 0.030 |
Why?
| | Algorithms | 1 | 2025 | 1844 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1182 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 441 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 980 | 0.030 |
Why?
| | Pediatric Obesity | 1 | 2024 | 637 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2019 | 565 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 843 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1241 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 869 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 184 | 0.030 |
Why?
| | Family Planning Services | 1 | 2015 | 93 | 0.030 |
Why?
| | Middle Aged | 2 | 2025 | 35971 | 0.020 |
Why?
| | Pregnancy Outcome | 1 | 2015 | 479 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1322 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2015 | 1098 | 0.020 |
Why?
| | Mice | 1 | 2022 | 18261 | 0.010 |
Why?
| | Animals | 1 | 2022 | 37948 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|